2010;298(5):H145465
has served as a consultant, advisory board member or speaker for Abbott, Angelini, Aquestive, Arvelle Therapeutics, Aucta Pharmaceuticals, Dr Reddys, Eisai, Jazz Pharmaceuticals, Neurelis, Neurona, Paladin, SK Life Science, Sunovion, UCB Pharma, UNEEG, UniQure, is a member of the Medical Advisory Board of Stratus and of the Scientific Advisory Board of OB Pharma, is on DSMB of Neurona Therapeutics for the NRTX-1001 trial, is co-founder and the CEO of PrevEp, and has received research support from CURE/Department of Defense and from the NIH/SBIR
World Journal of Diabetes, 12(12), 20362049
When Wegovy is covered, initial authorization and reauthorization may be required
Frequency of Side Effects Studies show that almost half of the patients on semaglutide report one or more side effects